DRVN
Driven Brands Holdings Inc.
DRVN has the edge over NIO overall, supported by stronger valuation and stronger modeled upside.
NIO
NIO Inc.
NIO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
DRVN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
DRVN's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
DRVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.8x | $11.53 | — |
| Current | 11x | $11.53 | — |
| Cheap | 14x | $14.15 | +23% |
| Fair | 120x | $125 | +981% |
| Expensive | 492x | $511 | +4335% |
Historical ranges are pointers, not guarantees.
DRVN's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 8.8x next year's earnings.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
DRVN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for DRVN, with profitability improving.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
DRVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.31 | +26% |
| Q2 2026 | $1.04 | +$2.74 |
| Q1 2026 | $1.12 | +$2.93 |
| Q4 2025 | $0.83 | +$2.65 |
| Q3 2025 | -$1.24 | -4233% |
| Q2 2025 | -$1.70 | +$3.01 |
| Q1 2025 | -$1.81 | +$2.86 |
| Q4 2024 | -$1.82 | +$2.71 |
| Q3 2024 | $0.03 | +$4.31 |
DRVN has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
DRVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $507.4M | -7.9% |
| Q1 2026 | $484.4M | -6.1% |
| Q4 2025 | $460.1M | -18% |
| Q3 2025 | $535.7M | -9.5% |
| Q2 2025 | $551M | -9.9% |
| Q1 2025 | $516.2M | -9.8% |
| Q4 2024 | $564.1M | +1.9% |
| Q3 2024 | $591.7M | +1.8% |
DRVN's revenue has slid since its 2024 peak: $507M last quarter, down 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +7.5 points |
| Q1 2026 | 14% | +2.1 points |
| Q4 2025 | 17% | +74 points |
| Q3 2025 | 12% | +4.9 points |
| Q2 2025 | 6.9% | -6.2 points |
| Q1 2025 | 12% | +1.6 points |
| Q4 2024 | -57% | -65 points |
| Q3 2024 | 6.7% | +163 points |
DRVN has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over DRVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
DRVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $28.9M | +221% |
| Q1 2026 | $23.1M | +22% |
| Q4 2025 | $36.2M | +$72.4M |
| Q3 2025 | $39.5M | +4.1% |
| Q2 2025 | $9M | +$28.5M |
| Q1 2025 | $18.9M | +$48.1M |
| Q4 2024 | -$36.3M | +$54.5M |
| Q3 2024 | $37.9M | +$103M |
DRVN has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
DRVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 5.6x | High |
| Q1 2025 | 71.8x | High |
| Q4 2024 | 63.3x | High |
| Q3 2024 | 6.4x | High |
| Q2 2023 | 5.2x | High |
| Q1 2023 | 7.5x | High |
DRVN's net debt is about 4.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DRVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 28.0 | Neutral |
DRVN's weekly RSI is 42 (neutral) and its Stochastic is 28 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
DRVN PE vs Consumer Cyclical Sector
| Metric | DRVN | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 0 | 50 | 50 pts below |
DRVN is trading at 11x earnings, a 38% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
DRVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 3.1% below |
| 20 week MA | $12.9 | 11% below |
| 50 week MA | $13.5 | 14% below |
| 100 week MA | $15.0 | 23% below |
| 200 week MA | $16.3 | 29% below |
DRVN is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
DRVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.7 | $33.3 | +25% |
| 2022 | $33.3 | $26.8 | -20% |
| 2023 | $26.8 | $14.3 | -47% |
| 2024 | $14.3 | $16.2 | +14% |
| 2025 | $16.2 | $14.8 | -8.6% |
| 2026 YTD | $14.8 | $11.5 | -22% |
DRVN has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.